The rapid rise of weight loss drugs Wegovy and Mounjaro is generating a host of new product lines as companies hope to land ...
Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are ...
Telehealth company Hims & Hers announced they will begin selling off-brand GLP-1 drugs similar to Ozempic and Wegovy at a ...
Public interest in weight loss drugs like Wegovy and Ozempic is surging, but national data on dispensing patterns in the United States is surprisingly scarce. Now, a national study from Michigan ...
While the UK stock market is rising, the Diageo share price is falling. Here, Edward Sheldon looks at what’s going on with ...
Copyright 2024 The Associated Press. All Rights Reserved. New research shows the number of 12- to 25-year-olds who used diabetes and obesity drugs such as Wegovy and ...
Giving obese children semaglutide could reduce their risk by 90 per cent. It comes after Diabetes UK revealed obesity has ...
The new generation of weight-loss drugs were initially developed to treat diabetes and work by mimicking a hormone that regulates insulin levels and appetite. When celebrities started shedding ...
It was ironic that the confession came midway through dinner. “I’ve started taking Ozempic,” my friend whispered in between small mouthfuls of the Thai green curry I’d just made for us.
Appetite suppressing drugs are becoming a hot topic of conversation, with doctors now suggesting they could have important clinical benefits not just limited to weight loss. A new five-year study ...
Anti-obesity jabs could reduce the risk of heart attacks and strokes in people even if they fail to lose much weight, according to a study funded by a drug manufacturer. The five-year study ...
Share on Pinterest A trio of new studies suggest that people who use GLP-1 drugs like Ozempic and Wegovy may be more likely to develop ‘stomach paralysis’ (gastroparesis). SeventyFour/Getty ...